glp-1 kidney protection agonists in the treatment of chronic disease in type 2 diabetes and obesity Full article: Advancing kidney protection
Description
March 9, 2021
water or milk
Controlled environments in animal laboratories cannot recapitulate the complexity of real-world clinical settings
Sometimes, non-event experiences were reported with no noticeable effects
